NFKB1 and neoplasm: Thus far, more than 800 therapeutic compounds that inhibit either activation or function of NF-κB have been identified, including a variety of natural and synthetic molecules [7] which in turn have shown growth inhibitory effects in this high grade tumor [24–29].